Bladder Wall Plexiform Neurofibromatosis in A Patient with NF1: Case Report and Literature Review

While von Recklinghausen provided a detailed description of the clinical entity of neurofibromatosis and is credited with its discovery, Smith initially described the condition in 1849. With an estimated frequency of one in every 3000 live births, it is a hereditary dysgenesis transmitted as a Mendelian dominant trait. It is a main neural crest derivation condition that also affects the nerve sheath's fibroblasts, Schwann cells, and supportive mesenchymal elements.